Skip to content
The Yangtzeer

The Yangtzeer

Covering the people, capital and innovation shaping the Yangtze River Delta

  • Home
  • News
    • Deals
    • Heavy Hitters
    • Startups
    • Policy
    • Research
  • Feature
    • Industry Pulse
    • Unicorn Club
    • Cluster Spotlight
    • Policy Decoded
  • Opinion
    • Editor’s View
    • Guest Posts
  • People
    • Old Guard
    • New Wave
    • Capital Journal
  • About
  • Contact
  • Privacy Policy
  • Home
  • cannabinoid

Tag: cannabinoid

  • News
  • Research

Zhejiang University study finds path to non-addictive pain relief drug

Yangtzeer observers2026-04-142026-04-1403 mins

Cannabinoid compounds are known to be effective in treating conditions such as chronic pain, anxiety and epilepsy, but their clinical use has been constrained by risks of addiction and other side effects.

Read More

Recent News

  • Hangzhou bets on insuring failure to fuel early-stage innovation
  • Zhejiang holds steady with 10 Fortune Global 500 companies
  • Standard Robots’ IPO gamble puts China’s robotics boom under scrutiny
  • Today’s Yangtze funding roundup: Medical AI, drug discovery, AI infrastructure
  • Alibaba launches China’s first real-time voice AI agent

Archives

  • July 2026
  • June 2026
  • May 2026
  • April 2026
  • March 2026
July 2026
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  
« Jun    
Copyright © 2026 The Yangtzeer. All rights reserved. Powered By BlazeThemes.